Cargando…

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype

A pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is a signature of favorable prognosis in breast cancer. The aim of this study was to assess the accuracy of magnetic resonance imaging (MRI) in predicting the pCR after NAC. 265 women with stage II or III breast cancer who unde...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukuda, Takayo, Horii, Rie, Gomi, Naoya, Miyagi, Yumi, Takahashi, Shunji, Ito, Yoshinori, Akiyama, Futoshi, Ohno, Shinji, Iwase, Takuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766139/ https://www.ncbi.nlm.nih.gov/pubmed/27026849 http://dx.doi.org/10.1186/s40064-016-1800-x

Ejemplares similares

Survival in Cytologically Proven Node-Positive Breast Cancer Patients with Nodal Pathological Complete Response after Neoadjuvant Chemotherapy
por: Inari, Hitoshi, et al.
Publicado: (2020)

Usefulness of second-look ultrasonography using anatomical breast structures as indicators for magnetic resonance imaging-detected breast abnormalities
por: Izumori, Ayumi, et al.
Publicado: (2019)

Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer
por: Fukada, Ippei, et al.
Publicado: (2016)

The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel
por: Fukada, Ippei, et al.
Publicado: (2017)

Clinicopathological features of breast cancer patients with internal mammary and/or supraclavicular lymph node recurrence without distant metastasis
por: Inari, Hitoshi, et al.
Publicado: (2020)

Skin invasion and prognosis in node negative breast cancer: a retrospective study
por: Tada, Keiichiro, et al.
Publicado: (2008)

Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype
por: Maeshima, Yurina, et al.
Publicado: (2021)

Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer
por: Tada, Keiichiro, et al.
Publicado: (2010)

Proposal of a novel method for observing the breast by high-resolution ultrasound imaging: understanding the normal breast structure and its application in an observational method for detecting deviations
por: Izumori, Ayumi, et al.
Publicado: (2011)

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
por: Honma, Naoko, et al.
Publicado: (2015)

Intratumoral heterogeneity, treatment response, and survival outcome of ER‐positive HER2‐positive breast cancer
por: Teruya, Natsuki, et al.
Publicado: (2023)

Clinical outcomes and prognostic factors in patients with stage II-III breast cancer treated with neoadjuvant chemotherapy followed by surgery and postmastectomy radiation therapy in the modern treatment era
por: Nakajima, Naomi, et al.
Publicado: (2018)

A new molecular-based lymph node staging classification determines the prognosis of breast cancer patients
por: Osako, Tomo, et al.
Publicado: (2017)

Decreased hormonal sensitivity after childbirth rather than the tumor size influences the prognosis of very young breast cancer patients
por: Makita, Masujiro, et al.
Publicado: (2015)

Combination chemotherapy with mitomycin C and methotrexate is active against metastatic HER2-negative breast cancer even after treatment with anthracycline, taxane, capecitabine, and vinorelbine
por: Fukuda, Takayo, et al.
Publicado: (2015)

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers
por: Shimada, Satoko, et al.
Publicado: (2019)

Clear Cell Sarcoma of the Neck Which Metastasized to the Mammary Gland
por: Fukada, Ippei, et al.
Publicado: (2013)

Cystoid Macular Edema during Treatment with Paclitaxel and Bevacizumab in a Patient with Metastatic Breast Cancer: A Case Report and Literature Review
por: Yokoe, Takamichi, et al.
Publicado: (2017)

Altered lymphatic drainage patterns in re-operative sentinel lymph node biopsy for ipsilateral breast tumor recurrence
por: Sato, Ayaka, et al.
Publicado: (2019)

Metastatic ovarian cancer spreading into mammary ducts mimicking an in situ component of primary breast cancer: a case report
por: Maeshima, Yurina, et al.
Publicado: (2021)

Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: a retrospective study
por: Kobayashi, Takayuki, et al.
Publicado: (2016)

Imatinib could be a new strategy for pulmonary hypertension caused by pulmonary tumor thrombotic microangiopathy in metastatic breast cancer
por: Fukada, Ippei, et al.
Publicado: (2016)

Ductal Carcinoma in situ Detected during Prospective MR Imaging Screening of a Woman with a BRCA2 Mutation: The First Case Report in Japan
por: Tozaki, Mitsuhiro, et al.
Publicado: (2017)

Comparison of different definitions of pathologic complete response in operable breast cancer: a pooled analysis of three prospective neoadjuvant studies of JBCRG
por: Kuroi, Katsumasa, et al.
Publicado: (2014)

A Case of Recurrent Breast Cancer Identified by Pulmonary Tumor Thrombotic Microangiopathy
por: Abe, Tomomi, et al.
Publicado: (2017)

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ
por: Osako, Tomo, et al.
Publicado: (2014)

Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
por: Horii, R, et al.
Publicado: (2007)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

Evaluating the usefulness of breast strain elastography for intraductal lesions
por: Kokubu, Yumi, et al.
Publicado: (2021)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

MO33-7 Preparedness for COVID-19 pandemic and impact on medical oncology for breast cancer
por: Inagaki, Lina, et al.
Publicado: (2021)

Visual Evaluation of Ultrafast MRI in the Assessment of Residual Breast Cancer after Neoadjuvant Systemic Therapy: A Preliminary Study Association with Subtype
por: Honda, Maya, et al.
Publicado: (2022)

Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes
por: Adham, Sirin A., et al.
Publicado: (2022)

Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins
por: Asakawa, Hideki, et al.
Publicado: (2010)

Frozen section is superior to imprint cytology for the intra-operative assessment of sentinel lymph node metastasis in Stage I Breast cancer patients
por: Mori, Miki, et al.
Publicado: (2006)

Accurate staging of axillary lymph nodes from breast cancer patients using a novel molecular method
por: Osako, T, et al.
Publicado: (2011)

Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors
por: Abe, Shinya, et al.
Publicado: (2015)

Common Peak Approach Using Mass Spectrometry Data Sets for Predicting the Effects of Anticancer Drugs on Breast Cancer
por: Ushijima, Masaru, et al.
Publicado: (2007)

Combinational Treatment of Doxorubicin With Neoadjuvant Docetaxel for Different Subtypes of Patients With Breast Cancer
por: Wang, Ling-Cheng, et al.
Publicado: (2020)

Interstitial lung disease associated with adjuvant and neoadjuvant chemotherapy in early breast cancer
por: Tezuka, Kenji, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_udkj3fjgoc72gg60kh0ad6vi89